Company Search:
Advanced Search
Sponsored Links
BAYER AG- ADR Company Snapshot
BAYER AG- ADR operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares BAYER AG- ADR with three other companies in this sector in the United States: Merck & Co. , Inc. (2016 sales of $39.81 billion of which 88% was Merck Pharmaceutical), Novartis AG ($49.44 billion of which 66% was innovative medicines), and Pfizer Inc. ($52.82 billion of which 55% was Operating Segment-Global Innovative Phar).

Sales Analysis. BAYER AG- ADR reported sales of $51.62 billion for the year ending December of 2016. This represents a very small increase of 1.0% versus 2015, when the company's sales were $51.09 billion. Despite this increase, sales are still below the level achieved in 2014, when BAYER AG- ADR reported sales of $55.77 billion. The sales level in 2016 was fairly close to the level five years ago: in 2011, BAYER AG- ADR had sales of $51.05 billion. Sales of Reconciliations saw an increase that was more than double the company's growth rate: sales were up 50.1% in 2016, from $4.41 million to $6.62 million. BAYER AG- ADR also saw significant increases in sales in Pharmaceuticals and Biological Products (up 19.5% to $18.12 billion) . Not all segments of BAYER AG- ADR experienced an increase in sales in 2016: sales of Consumer Care fell 33.8% to $6.66 billion. BAYER AG- ADR also experienced decreases in sales in Cropscience (down 4.3% to $10.94 billion) and All Other Segments (down 4.9% to $1.15 billion) .
  Stock Performance Chart for BAYER AG- ADR
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 115.77
(Figures in U.S. Dollars)
1 Week 0.7%   13 Weeks 4.2%  
4 Weeks 12.8%   52 Weeks 1.1%  
  Ticker: BAYA Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 51,620,348,370
(Year Ending Jan 2017).
Employees: 115,200
  Currency: U.S. Dollars Market Cap: 95,733,051,882
  Fiscal Yr Ends: December Shares Outstanding: 826,947,808
  Share Type: Stammaktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.